Ansiling, Baby Girl .

HRN: 26-09-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2024
AMPICILLIN 250MG (VIAL)
10/30/2024
11/06/2024
IV
160mg
Q12
PSNB
Waiting Final Action 
10/30/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/30/2024
11/06/2024
IV
48mg
Q24
PSNB
Waiting Final Action 
10/30/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/30/2024
11/06/2024
IV
32mg
Q8
PSNB; TC Neonatal Tetanus
Waiting Final Action 
10/30/2024
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
10/30/2024
10/30/2024
TOPICAL
Once
Once
Eye Prophylaxis
Waiting Final Action 
10/30/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
10/30/2024
11/05/2024
IV
16mg
OD
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: